Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver-Kidney Transplantation.

Lunsford KE, Agopian VG, Yi SG, Nguyen DTM, Graviss EA, Harlander-Locke MP, Saharia A, Kaldas FM, Mobley CM, Zarrinpar A, Hobeika M, Veale JL, Podder H, Farmer DG, Knight RJ, Danovitch GM, Gritsch HA, Li XC, Ghobrial RM, Busuttil RW, Gaber AO.

Transplantation. 2019 Oct 23. doi: 10.1097/TP.0000000000003040. [Epub ahead of print]

PMID:
31651787
2.

Impact of Rifaximin Therapy on Ischemia/Reperfusion Injury in Liver Transplantation: A Propensity Score-Matched Analysis.

Ito T, Nakamura K, Kageyama S, Korayem IM, Hirao H, Kadono K, Aziz J, Younan S, DiNorcia J 3rd, Agopian VG, Yersiz H, Farmer DG, Busuttil RW, Kupiec-Weglinski JW, Kaldas FM.

Liver Transpl. 2019 Dec;25(12):1778-1789. doi: 10.1002/lt.25633. Epub 2019 Nov 4.

PMID:
31509643
3.

Intraoperative hypertension and thrombocytopenia associated with intracranial hemorrhage after liver transplantation.

Gao W, Li J, Nguyen-Buckley C, Nguyen-Lee J, Wray C, Agopian V, Busuttil RW, Steadman RH, Xia VW.

Transplantation. 2019 Aug 2. doi: 10.1097/TP.0000000000002899. [Epub ahead of print]

PMID:
31397798
4.

Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells.

Dong J, Jan YJ, Cheng J, Zhang RY, Meng M, Smalley M, Chen PJ, Tang X, Tseng P, Bao L, Huang TY, Zhou D, Liu Y, Chai X, Zhang H, Zhou A, Agopian VG, Posadas EM, Shyue JJ, Jonas SJ, Weiss PS, Li M, Zheng G, Yu HH, Zhao M, Tseng HR, Zhu Y.

Sci Adv. 2019 Jul 31;5(7):eaav9186. doi: 10.1126/sciadv.aav9186. eCollection 2019 Jul.

5.

Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients.

Firl DJ, Sasaki K, Agopian VG, Gorgen A, Kimura S, Dumronggittigule W, McVey JC, Iesari S, Mennini G, Vitale A, Finkenstedt A, Onali S, Hoppe-Lotichius M, Vennarecci G, Manzia TM, Nicolini D, Avolio AW, Agnes S, Vivarelli M, Tisone G, Ettorre GM, Otto G, Tsochatzis E, Rossi M, Viveiros A, Cillo U, Markmann JF, Ikegami T, Kaido T, Lai Q, Sapisochin G, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group, Aucejo FN.

Hepatology. 2019 Jun 27. doi: 10.1002/hep.30838. [Epub ahead of print]

PMID:
31243778
6.

Factors predicting kidney delayed graft function among recipients of simultaneous liver-kidney transplantation: A single-center experience.

Korayem IM, Agopian VG, Lunsford KE, Gritsch HA, Veale JL, Lipshutz GS, Yersiz H, Serrone CL, Kaldas FM, Farmer DG, Bunnapradist S, Danovitch GM, Busuttil RW, Zarrinpar A.

Clin Transplant. 2019 Jun;33(6):e13569. doi: 10.1111/ctr.13569. Epub 2019 May 7.

7.

Moving toward personalizing MELD exceptions in liver transplantation for hepatocellular carcinoma.

Parikh ND, Agopian VG.

Am J Transplant. 2019 Aug;19(8):2153-2154. doi: 10.1111/ajt.15389. Epub 2019 May 6. No abstract available.

PMID:
30953598
8.

Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer.

Dong J, Zhang RY, Sun N, Smalley M, Wu Z, Zhou A, Chou SJ, Jan YJ, Yang P, Bao L, Qi D, Tang X, Tseng P, Hua Y, Xu D, Kao R, Meng M, Zheng X, Liu Y, Vagner T, Chai X, Zhou D, Li M, Chiou SH, Zheng G, Di Vizio D, Agopian VG, Posadas E, Jonas SJ, Ju SP, Weiss PS, Zhao M, Tseng HR, Zhu Y.

ACS Appl Mater Interfaces. 2019 Apr 17;11(15):13973-13983. doi: 10.1021/acsami.9b01406. Epub 2019 Apr 2.

9.

Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium.

DiNorcia J, Florman SS, Haydel B, Tabrizian P, Ruiz RM, Klintmalm GB, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial M, Nydam TL, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Markovic D, Busuttil RW, Agopian VG.

Ann Surg. 2019 Mar 5. doi: 10.1097/SLA.0000000000003253. [Epub ahead of print]

PMID:
30870180
10.

Assessment of Anastomotic Biliary Complications in Adult Patients Undergoing High-Acuity Liver Transplant.

Kaldas FM, Korayem IM, Russell TA, Agopian VG, Aziz A, DiNorcia J, Farmer DG, Yersiz H, Hiatt JR, Busuttil RW.

JAMA Surg. 2019 May 1;154(5):431-439. doi: 10.1001/jamasurg.2018.5527.

PMID:
30758485
11.

Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.

Zarrinpar A, Faltermeier CM, Agopian VG, Naini BV, Harlander-Locke MP, Kaldas FM, Farmer DG, Busuttil RW.

Liver Int. 2019 Mar;39(3):531-539. doi: 10.1111/liv.14002. Epub 2018 Dec 2.

12.

Incidence, Predictors, and Outcomes of New-Onset Left Ventricular Systolic Dysfunction After Orthotopic Liver Transplantation.

Eyvazian VA, Gordin JS, Yang EH, Aksoy O, Honda HM, Busuttil RW, Agopian VG, Vorobiof G.

J Card Fail. 2019 Mar;25(3):166-172. doi: 10.1016/j.cardfail.2018.10.013. Epub 2018 Nov 6.

13.

Minimizing central line-associated bloodstream infections in a high-acuity liver transplant intensive care unit.

Russell TA, Fritschel E, Do J, Donovan M, Keckeisen M, Agopian VG, Farmer DG, Wang T, Rubin Z, Busuttil RW, Kaldas FM.

Am J Infect Control. 2019 Mar;47(3):305-312. doi: 10.1016/j.ajic.2018.08.006. Epub 2018 Oct 15.

PMID:
30333081
14.

Preoperative beta blockade and severe intraoperative bradycardia in liver transplantation.

Fu H, Sun K, Li J, Gong W, Agopian V, Yan M, Busuttil RW, Steadman RH, Xia VW.

Clin Transplant. 2018 Dec;32(12):e13422. doi: 10.1111/ctr.13422. Epub 2018 Oct 27.

PMID:
30312516
15.

Elimination of Hepatitis C in Liver Transplant Recipients.

Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW.

J Clin Transl Hepatol. 2018 Sep 28;6(3):247-250. doi: 10.14218/JCTH.2017.00079. Epub 2018 Jun 8.

16.

Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality.

Aby ES, Lee E, Saggi SS, Viramontes MR, Grotts JF, Agopian VG, Busuttil RW, Saab S.

J Clin Gastroenterol. 2019 Oct;53(9):680-685. doi: 10.1097/MCG.0000000000001109.

PMID:
30180152
17.

Use of hepatitis C-positive grafts in hepatitis C-negative liver transplant recipients is cost effective.

Saab S, Kardashian A, Saggi S, Choi G, Agopian V, Tong MJ.

Clin Transplant. 2018 Oct;32(10):e13383. doi: 10.1111/ctr.13383. Epub 2018 Sep 15.

PMID:
30129981
18.

Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies.

Halazun KJ, Tabrizian P, Najjar M, Florman S, Schwartz M, Michelassi F, Samstein B, Brown RS Jr, Emond JC, Busuttil RW, Agopian VG.

Ann Surg. 2018 Oct;268(4):690-699. doi: 10.1097/SLA.0000000000002964.

PMID:
30048307
19.

Incidence, Etiology, and Outcomes of Altered Mental Status in the Perioperative Setting of Liver Transplantation.

Lening C, Agopian VG, Busuttil RW, Liebeskind DS.

Neurohospitalist. 2018 Jul;8(3):124-128. doi: 10.1177/1941874417738689. Epub 2017 Nov 7.

20.

Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study.

Jacobs JP, Dong TS, Agopian V, Lagishetty V, Sundaram V, Noureddin M, Ayoub WS, Durazo F, Benhammou J, Enayati P, Elashoff D, Goodman MT, Pisegna J, Hussain S.

Hepatol Res. 2018 Dec;48(13):1108-1117. doi: 10.1111/hepr.13207. Epub 2018 Jul 30.

21.

A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.

Court CM, Hou S, Winograd P, Segel NH, Li QW, Zhu Y, Sadeghi S, Finn RS, Ganapathy E, Song M, French SW, Naini BV, Sho S, Kaldas FM, Busuttil RW, Tomlinson JS, Tseng HR, Agopian VG.

Liver Transpl. 2018 Jul;24(7):946-960. doi: 10.1002/lt.25062.

22.

Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.

Lunsford KE, Court C, Seok Lee Y, Lu DS, Naini BV, Harlander-Locke MP, Busuttil RW, Agopian VG.

Liver Transpl. 2018 Oct;24(10):1384-1397. doi: 10.1002/lt.25058.

23.

NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.

Jan YJ, Chen JF, Zhu Y, Lu YT, Chen SH, Chung H, Smalley M, Huang YW, Dong J, Chen LC, Yu HH, Tomlinson JS, Hou S, Agopian VG, Posadas EM, Tseng HR.

Adv Drug Deliv Rev. 2018 Feb 1;125:78-93. doi: 10.1016/j.addr.2018.03.006. Epub 2018 Mar 15. Review.

24.

Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.

Court CM, Ankeny JS, Sho S, Winograd P, Hou S, Song M, Wainberg ZA, Girgis MD, Graeber TG, Agopian VG, Tseng HR, Tomlinson JS.

Ann Surg Oncol. 2018 Apr;25(4):1000-1008. doi: 10.1245/s10434-017-6290-8. Epub 2018 Feb 13.

25.

One Thousand Pediatric Liver Transplants During Thirty Years: Lessons Learned.

Venick RS, Farmer DG, Soto JR, Vargas J, Yersiz H, Kaldas FM, Agopian VG, Hiatt JR, McDiarmid SV, Busuttil RW.

J Am Coll Surg. 2018 Apr;226(4):355-366. doi: 10.1016/j.jamcollsurg.2017.12.042. Epub 2018 Feb 2.

PMID:
29410290
26.

Optimizing the Management of Abnormal Liver Function Tests after Orthotopic Liver Transplant: A Systems-Based Analysis of Health Care Utilization.

Russell TA, Angarita SAK, Showen A, Agopian V, Busuttil RW, Kaldas FM.

Am Surg. 2017 Oct 1;83(10):1152-1156.

PMID:
29391114
27.

Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.

Agopian VG, Harlander-Locke MP, Markovic D, Dumronggittigule W, Xia V, Kaldas FM, Zarrinpar A, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW.

JAMA Surg. 2018 May 1;153(5):436-444. doi: 10.1001/jamasurg.2017.5040. Erratum in: JAMA Surg. 2018 May 1;153(5):498.

28.

Use of Entrustable Professional Activities in the Assessment of Surgical Resident Competency.

Wagner JP, Lewis CE, Tillou A, Agopian VG, Quach C, Donahue TR, Hines OJ.

JAMA Surg. 2018 Apr 1;153(4):335-343. doi: 10.1001/jamasurg.2017.4547.

29.

Response: "Which is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?"

Agopian VG, Chapman WC, Busuttil RW; United States Multicenter Hepatocellular Carcinoma Transplant Consortium (UMHTC).

Ann Surg. 2018 Dec;268(6):e57-e60. doi: 10.1097/SLA.0000000000002577. No abstract available.

PMID:
29064906
30.

Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C.

Aby E, Jimenez MA, Grotts JF, Agopian V, French SW, Busuttil RW, Saab S.

J Clin Transl Hepatol. 2017 Sep 28;5(3):197-202. doi: 10.14218/JCTH.2016.00073. Epub 2017 May 28.

31.

Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection.

Shen MY, Chen JF, Luo CH, Lee S, Li CH, Yang YL, Tsai YH, Ho BC, Bao LR, Lee TJ, Jan YJ, Zhu YZ, Cheng S, Feng FY, Chen P, Hou S, Agopian V, Hsiao YS, Tseng HR, Posadas EM, Yu HH.

Adv Healthc Mater. 2018 Feb;7(3). doi: 10.1002/adhm.201700701. Epub 2017 Sep 11.

32.

Gastrointestinal Mucormycosis After Orthotopic Liver Transplantation Presenting as Femoral Nerve Palsy: A Case Report and Review of the Literature.

Gaut D, Cone BD, Gregson AL, Agopian VG.

Transplant Proc. 2017 Sep;49(7):1608-1614. doi: 10.1016/j.transproceed.2017.03.074. Epub 2017 Jul 26. Review.

PMID:
28755897
33.

Venovenous Bypass Is Associated With a Lower Incidence of Acute Kidney Injury After Liver Transplantation in Patients With Compromised Pretransplant Renal Function.

Sun K, Hong F, Wang Y, Agopian VG, Yan M, Busuttil RW, Steadman RH, Xia VW.

Anesth Analg. 2017 Nov;125(5):1463-1470. doi: 10.1213/ANE.0000000000002311.

PMID:
28742776
34.

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma.

Sandler KA, Veruttipong D, Agopian VG, Finn RS, Hong JC, Kaldas FM, Sadeghi S, Busuttil RW, Lee P.

Adv Radiat Oncol. 2016 Oct 29;1(4):237-243. doi: 10.1016/j.adro.2016.10.008. eCollection 2016 Oct-Dec.

35.

Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.

Court CM, Harlander-Locke MP, Markovic D, French SW, Naini BV, Lu DS, Raman SS, Kaldas FM, Zarrinpar A, Farmer DG, Finn RS, Sadeghi S, Tomlinson JS, Busuttil RW, Agopian VG.

Liver Transpl. 2017 Sep;23(9):1123-1132. doi: 10.1002/lt.24811.

36.

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW.

Ann Surg. 2017 Sep;266(3):525-535. doi: 10.1097/SLA.0000000000002381.

PMID:
28654545
37.
38.

Peritransplant pancreatitis: A marker of high mortality and graft failure in liver transplant patients.

Russell TA, Park S, Agopian VG, Zarrinpar A, Farmer DG, O'Neill S, Korayem I, Ebaid S, Gornbein J, Busuttil RW, Kaldas FM.

Liver Transpl. 2017 Jul;23(7):925-932. doi: 10.1002/lt.24760.

39.

Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.

Lee MW, Raman SS, Asvadi NH, Siripongsakun S, Hicks RM, Chen J, Worakitsitisatorn A, McWilliams J, Tong MJ, Finn RS, Agopian VG, Busuttil RW, Lu DSK.

Hepatology. 2017 Jun;65(6):1979-1990. doi: 10.1002/hep.29098. Epub 2017 Apr 28.

PMID:
28170115
40.

Longterm follow-up of small pancreatic cystic lesions in liver transplant recipients.

Vidhyarkorn S, Siripongsakun S, Yu J, Sayre J, Agopian VG, Durazo F, Lu DS.

Liver Transpl. 2017 Mar;23(3):324-329. doi: 10.1002/lt.24680. Epub 2017 Feb 8.

41.

Intestinal Perforation Following Ileoscopy Through a Prolapsed Stoma in an Pediatric Intestinal Transplant Recipient With an Unrecognized Parastomal Hernia.

Mehrotra P, Yeh J, Hall TR, Agopian VG, Farmer DG, Marcus EA, Venick RS, Wozniak LJ.

ACG Case Rep J. 2016 Sep 14;3(4):e123. eCollection 2016 Aug.

42.

The Timing of Reoperation for Incidental Gallbladder Cancer: Sooner or Later?

Agopian VG, Hiatt JR.

JAMA Surg. 2017 Feb 1;152(2):149. doi: 10.1001/jamasurg.2016.3643. No abstract available.

PMID:
27784061
43.

Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.

Agopian VG, Harlander-Locke MP, Markovic D, Zarrinpar A, Kaldas FM, Cheng EY, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW.

JAMA Surg. 2017 Jan 1;152(1):55-64. doi: 10.1001/jamasurg.2016.3310.

44.

Myocardial injury in patients with hemodynamic derangements during and/or after liver transplantation.

Huang S, Apinyachon W, Agopian VG, Wray CL, Busuttil RW, Steadman RH, Xia VW.

Clin Transplant. 2016 Dec;30(12):1552-1557. doi: 10.1111/ctr.12855. Epub 2016 Oct 14.

PMID:
27653509
45.

Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment.

Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, Vibert E, Cherqui D, Grant DR, Hernandez-Alejandro R, Dale CH, Cucchetti A, Pinna A, Hwang S, Lee SG, Agopian VG, Busuttil RW, Rizvi S, Heimbach JK, Montenovo M, Reyes J, Cesaretti M, Soubrane O, Reichman T, Seal J, Kim PT, Klintmalm G, Sposito C, Mazzaferro V, Dutkowski P, Clavien PA, Toso C, Majno P, Kneteman N, Saunders C, Bruix J; iCCA International Consortium.

Hepatology. 2016 Oct;64(4):1178-88. doi: 10.1002/hep.28744. Epub 2016 Aug 24.

PMID:
27481548
46.

Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation: Impact of Treatment Modality and Recurrence Characteristics.

Bodzin AS, Lunsford KE, Markovic D, Harlander-Locke MP, Busuttil RW, Agopian VG.

Ann Surg. 2017 Jul;266(1):118-125. doi: 10.1097/SLA.0000000000001894.

PMID:
27433914
47.

Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells.

Chen JF, Zhu Y, Lu YT, Hodara E, Hou S, Agopian VG, Tomlinson JS, Posadas EM, Tseng HR.

Theranostics. 2016 Jun 15;6(9):1425-39. doi: 10.7150/thno.15359. eCollection 2016. Review.

48.

Avoiding Futility in Simultaneous Liver-kidney Transplantation: Analysis of 331 Consecutive Patients Listed for Dual Organ Replacement.

Lunsford KE, Bodzin AS, Markovic D, Zarrinpar A, Kaldas FM, Gritsch HA, Xia V, Farmer DG, Danovitch GM, Hiatt JR, Busuttil RW, Agopian VG.

Ann Surg. 2017 May;265(5):1016-1024. doi: 10.1097/SLA.0000000000001801.

PMID:
27232249
49.

Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform.

Zarrinpar A, Lee DK, Silva A, Datta N, Kee T, Eriksen C, Weigle K, Agopian V, Kaldas F, Farmer D, Wang SE, Busuttil R, Ho CM, Ho D.

Sci Transl Med. 2016 Apr 6;8(333):333ra49. doi: 10.1126/scitranslmed.aac5954.

50.

Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience.

Sheen V, Nguyen H, Jimenez M, Agopian V, Vangala S, Elashoff D, Saab S.

J Clin Transl Hepatol. 2016 Mar 28;4(1):20-5. doi: 10.14218/JCTH.2015.00034. Epub 2016 Mar 15.

Supplemental Content

Loading ...
Support Center